Carolyn Barber, MD on Nostr: ​In a real world cohort study​ of 106 long covid pts, investigators report in a ...

​In a real world cohort study​ of 106 long covid pts, investigators report in a preprint that antiviral treatment ​(Paxlovid) ​predicted clinical recovery​(OR 4.5)​ while anticoagulant therapy did not(OR 0.35). ​Biomarkers of neurodamage also declined quickly after 15 days of Pax.

​"Our​ results support a putative role for viral persistence in Long COVID pathogenesis but also indicate a large​ therapeutic window for Paxlovid and other antivirals.​" https://www.medrxiv.org/content/10.1101/2025.02.14.25322178v1.full.pdf #LongCovid #press